Hypothesis and TheoryPublished 17 September 2026Emerging mechanisms in dry eye disease: apoptosis-associated tear MicroRNAs and toxicant-related alterations of the glycocalyx and lipid raftsMazyar YazdaniFrontiers in Ophthalmologydoi 10.3389/fopht.2026.1924390
Clinical TrialPublished 17 July 2026Long-term Impact of Intravitreal Injections on the ocular surface; a 2-year follow-up studyAgni Malmin · Markus Vicente Tørud Olsen · Vilde Marie Thomseth · Inga-Britt Kjellevold Haugen · Tor Paaske Utheim · Vegard Asgeir ForsaaFrontiers in Ophthalmologydoi 10.3389/fopht.2026.1829818
Original ResearchPublished 3 June 2026Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implicationsWei Huang · Ziyi Wen · Konstantinos Tourmouzis · Liqun Huang · Sanford M. Goldstein · Ernest Natke · Robert Honkanen · Basil RigasFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1778440
